Berkeley Lights Unveils Revolutionary Optofluidic System, Beacon Select™, to Streamline Cell Line Development

Introducing a revolutionary new optofluidic system – a two-chip, single-cell device perfect for small to mid-sized biopharma and CDMOs/CROs. Now, you can have access to the Beacon® technology and cell line development-specific applications at an affordable price.

Berkeley Lights, Inc. (Nasdaq: BLI), a leader in life sciences tools, has unveiled the Beacon Select™ – the latest addition to its groundbreaking optofluidic system for cell line development (CLD). Building on the success of the original Beacon system, which boasts more than 130 installations worldwide, the Beacon Select offers customers optofluidic and NanoPen® chamber technology, along with proprietary CLD applications, in an optimized package that meets the research and budget requirements of new market segments.

The groundbreaking Beacon Select is the perfect solution for small to mid-sized biopharma and CDMOs/CROs looking to quickly and efficiently clone, culture, assay, and select top clones. This two-chip, single-cell optofluidic system enables scientists to get from cloning to selection of top-performing CHO cell lines in just a few days, with Opto® CLD and Opto® Assure Assays helping to reduce bioprocessing costs, improve the probability of success, and shorten timelines. Get the top clones for your project without the wait!

Berkeley Lights is introducing Beacon Select, a revolutionary new technology that offers customers the chance to purchase, lease, or rent reagents at a fraction of the cost of the current Beacon system. This groundbreaking offering is perfect for customers who don’t need the full Beacon capacity, while existing Beacon customers can now enjoy increased throughput and access to CLD applications. Beacon Select is the perfect way to make cutting edge technology accessible and affordable for everyone!

Berkeley Lights has revolutionized the market with the launch of its new Beacon Select platform, offering customers a more cost-effective and flexible configuration to enhance their cell line development. What’s more, the company is unveiling Beacon Quest by the second half of 2023, an optofluidic system tailored for academic research institutes and translational research centers. This pioneering technology promises to be an invaluable asset for customers, offering them the opportunity to break down barriers and access cutting-edge solutions.

Additional Features and Benefits of the Beacon Select

Revolutionize your cell line development with Beacon Select! This innovative system offers up to 2x higher cloning throughput and up to 50% faster timeline compared to traditional methods, while achieving 5x greater cloning efficiency than FACS and 10x higher than limiting dilution. Plus, its Custom Productivity Assay enables selection of clones secreting a wide variety of molecules, from antibodies to protein-based vaccines, enzymes, fusion proteins, antibody fragments, and cytokines – all on one single instrument! Get ready to experience the power of Beacon Select and take your projects to the next level.

About Berkeley Lights

Berkeley Lights is revolutionizing the life sciences industry with cutting-edge tools that enable and accelerate the development and commercialization of biotherapeutics and other cell-based products. Our platform is a comprehensive solution that includes proprietary consumables, advanced automation systems, and application software to capture deep phenotypic, functional, and genotypic information from thousands of single cells in parallel with unprecedented speed and accuracy. Berkeley Lights is setting a new industry standard for customers across the cell-based product value chain by providing the most advanced environment for rapid functional characterization of single cells at scale.

Forward-Looking Statements

Berkeley Lights is dedicated to providing customers with breakthrough products that exceed expectations. While we are confident that our products will perform as promised, there is always the potential for risks and uncertainties which could lead to actual results being different than expected. We are committed to continuous improvement and evolution, and actively work to identify and mitigate any potential risks. As such, we remain dedicated to providing our customers with the best products and services possible.

Leave a Comment